Botanical species · safety record

Heracleum candicans

The EFSA Compendium of Botanicals holds 11 constituent measurements for Heracleum candicans. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Heracleum candicans Wall. ex DC.

11Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Candibirins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Canditetrarins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Canditririns	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Furanocoumarins	Fruit unspecified	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Heraclenin	Roots and other underground parts	Solvent extraction	≤ 1.367 Percent	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Heraclenin	Roots and other underground parts	Solvent extraction	≥ 1.02 Percent	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Heraclenol	Roots and other underground parts	Solvent extraction	≥ 0.29 Percent	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Heraclenol	Roots and other underground parts	Solvent extraction	≤ 0.433 Percent	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Furanocoumarins	Roots and other underground parts	Solvent extraction	≥ 5.01 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Furanocoumarins	Roots and other underground parts	Solvent extraction	≤ 9.47 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Myrcene	Leaves	Essential oil	2.9 Percent	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Devagiri, G.M., Rastogi, J.S., Chand, R., Srivastava, L. Preliminary evaluation of some Hercleum candicans wall collections from Himachal Pradesh for furocoumarin content. Indian Drugs, 1995, vol. 32, no. 8, p. 381-386.
Rastogi, Subha., Pandey, Madan M., Rawat, Ajay K. S. Determination of heracienin and heracienol in Heracieum candicans DC by TLC. CHROMATOGRAPHIA, 2007, vol. 66, no. 7-8, p. 631-634. DOI
Taniguchi, Masahiko., Inoue, Atsuko., Shibano, Makio., Wang, Nian-He., Baba, Kimiye. Five condensed furanocoumarins from the root of Heracleum candicans Wall.. JOURNAL OF NATURAL MEDICINES, 2011, vol. 65, no. 2, p. 268-274. DOI
Chauhan, R. S., Nautiyal, M. C., Tava, A., Cecotti, R. Essential oil composition from leaves of Heracleum candicans Wall.: a sustainable method for extraction. JOURNAL OF ESSENTIAL OIL RESEARCH, 2014, vol. 26, no. 2, p. 130-132.
Inoue, Atsuko., Taniguchi, Masahiko., Shibano, Makio., Wang, Nian-He., Baba, Kimiye. Chemical studies on the root of Heracleum candicans Wall. (Part 3). JOURNAL OF NATURAL MEDICINES, 2010, vol. 64, no. 2, p. 175-181. DOI
Rawat, A. K. S., Singh, A. P., Singh, D. P., Pandey, M. M., Govindarajan, R., Srivastava, Sharad. Separation and Identification of Furocoumarin in Fruits of Heracleum candicans DC. by HPTLC. JOURNAL OF CHEMISTRY, 2013. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature